Hodgkin's lymphoma, mixed cellularity
MONDO:0004633A subtype of classical Hodgkin lymphoma with scattered Reed-Sternberg and Hodgkin cells in a diffuse or vaguely nodular mixed inflammatory background without nodular sclerosing fibrosis. (WHO, 2008)
Also known as: Hodgkin lymphoma, mixed cellularity, Hodgkin's disease mixed cellularity, Hodgkin's disease, mixed cellularity of unspecified site, Hodgkin's lymphoma mixed cellularity, MCCHL, MCHL, Mixed cellularity Classic Hodgkin lymphoma, classic Hodgkin lymphoma, mixed cellularity type
1901 clinical trials for this condition and its sub-types, 4 tagged with Hodgkin's lymphoma, mixed cellularity itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
New combo therapy aims to beat back advanced hodgkin lymphoma
Disease control OngoingThis phase 3 trial compares two immunotherapy drugs—nivolumab (Opdivo) and brentuximab vedotin (Adcetris)—when added to standard chemotherapy for people aged 12 and older with newly diagnosed stage III or IV classic Hodgkin lymphoma. The goal is to see which combination better de…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New strategy aims to tame common virus after stem cell transplants
Disease control OngoingThis study tests a modified plan to prevent and treat cytomegalovirus (CMV) infection in people with blood cancers who have had a donor stem cell transplant. CMV is a common virus that can cause serious problems after transplant. The study involves 153 participants and looks at w…
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC